Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Other Operating Expenses (2025)

Zenas BioPharma (ZBIO) has 2 years of Other Operating Expenses data on record, last reported at $5.0 million in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $5.0 million; the TTM value through Sep 2025 reached $5.0 million, changed N/A, while the annual FY2023 figure was $10.0 million, N/A changed from the prior year.
  • Other Operating Expenses reached $5.0 million in Q3 2025 per ZBIO's latest filing, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $5.0 million in Q3 2025 and bottomed at -$1000.0 in Q4 2024.